REVB Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics...

Stats
Dzisiejszy wolumen	24 418.00
Średni wolumen	230 101
Kapitalizacja rynkowa	3.87M
EPS	$0 ( 2024-04-04 )
Następna data zysków	( $-5.39 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.47
ATR14	$0.0170 (0.72%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-08	Tidmarsh George F	Sell	27 771	Common Stock
2023-10-16	Tidmarsh George F	Sell	1 845	Common Stock
2023-10-16	Tidmarsh George F	Sell	10 957	Common Stock
2023-09-27	Chawla Lakhmir S	Buy	0
2023-09-28	Tidmarsh George F	Sell	1 429	Common Stock

INSIDER POWER
-12.76
Last 48 transactions
Buy: 316 523 \| Sell: 2 020 596

Wolumen Korelacja

Długi: -0.15 (neutral)

Krótki: 0.29 (neutral)

Signal:(49.31) Neutral

Revelation Biosciences, Korelacja

10 Najbardziej pozytywne korelacje
KBNT	0.979
KSPN	0.979
VRM	0.976
CSSEN	0.974
IRBT	0.972
RDHL	0.962
AHPI	0.961
AXDX	0.96
IDBA	0.958
TKLF	0.957

10 Najbardziej negatywne korelacje
NVCN	-0.98
ROVR	-0.979
AVEO	-0.979
ITMR	-0.974
DVCR	-0.968
ATVI	-0.967
STAY	-0.966
INBK	-0.961
HCCI	-0.96
ADTH	-0.96

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Revelation Biosciences, Korelacja - Waluta/Towar

-0.44
( neutral )

-0.51
( weak negative )

0.00
( neutral )

-0.50
( neutral )

0.54
( weak )

0.34
( neutral )

Revelation Biosciences, Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-25 049.00 (0.00 %)
EPS:	$-0.530

FY	2023
Przychody:	$0
Zysk brutto:	$-25 049.00 (0.00 %)
EPS:	$-0.530

FY	2022
Przychody:	$0
Zysk brutto:	$-40 008.00 (0.00 %)
EPS:	$-600.77

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.310

Financial Reports:

No articles found.

Revelation Biosciences,

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a potential therapy for the treatment of chronic organ disease, including chronic kidney disease and non-alcoholic steatohepatitis; and REVDx-501, a rapid test kit, which is a point of care in vitro diagnostic test that has the potential to detect respiratory viral infections, such as SARS-CoV-2, Influenza A, Influenza B, parainfluenza, or respiratory syncytial virus. The company was founded in 2020 and is based in San Diego, California.